Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $121
Benzinga Newsdesk 22 hours ago
Analyst RatingsNewsPrice Target
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $94 to $121.
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $94 to $121.